Paper38937372
Stability of Protein Pharmaceuticals: Recent Advances.
Manning MC and 10 others. Pharm Res, 2024. Cited by 29 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stability of Protein Pharmaceuticals: Recent Advances. Papers, record 38937372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38937372
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Stability | Major topic |
| Proteins | Major topic |
| Drug Stability | Major topic |
| Humans | |
| Excipients | |
| Drug Compounding | |
| Chemistry, Pharmaceutical | |
| Animals | |
| Antibodies, Monoclonal |
Source PubMed
References1,015
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12,717,013 | Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor. | Protein Sci | 2003 | https://conductscience.org/library/papers/12717013 | PubMed |
| 2 | 26,821,017 | Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26821017 | PubMed |
| 3 | 37,229,604 | Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity. | MAbs | 2023 | https://conductscience.org/library/papers/37229604 | PubMed |
| 4 | 8,899,829 | Kinetics and mechanism of the cleavage of the peptide bond next to asparagine. | Peptides | 1996 | https://conductscience.org/library/papers/8899829 | PubMed |
| 5 | 20,223,286 | Formulation strategy and use of excipients in pulmonary drug delivery. | Int J Pharm | 2010 | https://conductscience.org/library/papers/20223286 | PubMed |
| 6 | 26,756,795 | Effect of Excipients on Liquid-Liquid Phase Separation and Aggregation in Dual Variable Domain Immunoglobulin Protein Solutions. | Mol Pharm | 2016 | https://conductscience.org/library/papers/26756795 | PubMed |
| 7 | 2,095,560 | Analytical approaches to the study of monoclonal antibody stability. | Pharm Res | 1990 | https://conductscience.org/library/papers/2095560 | PubMed |
| 8 | 28,522,393 | Protein aggregation: From background to inhibition strategies. | Int J Biol Macromol | 2017 | https://conductscience.org/library/papers/28522393 | PubMed |
| 9 | 16,400,901 | Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. | Ann Allergy Asthma Immunol | 2005 | https://conductscience.org/library/papers/16400901 | PubMed |
| 10 | 21,846,562 | Aggregation, stability, and formulation of human antibody therapeutics. | Adv Protein Chem Struct Biol | 2011 | https://conductscience.org/library/papers/21846562 | PubMed |
| 11 | 32,991,241 | Subcutaneous vaccine administration - an outmoded practice. | Hum Vaccin Immunother | 2021 | https://conductscience.org/library/papers/32991241 | PubMed |
| 12 | 18,567,545 | Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G. | J Chromatogr B Analyt Technol Biomed Life Sci | 2008 | https://conductscience.org/library/papers/18567545 | PubMed |
| 13 | 35,441,516 | Mechanism of Osmolyte Stabilization-Destabilization of Proteins: Experimental Evidence. | J Phys Chem B | 2022 | https://conductscience.org/library/papers/35441516 | PubMed |
| 14 | 22,734,583 | Deamidation accelerates amyloid formation and alters amylin fiber structure. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/22734583 | PubMed |
| 15 | 29,288,093 | Notorious but not understood: How liquid-air interfacial stress triggers protein aggregation. | Int J Pharm | 2018 | https://conductscience.org/library/papers/29288093 | PubMed |
| 16 | 24,142,697 | Cysteine racemization on IgG heavy and light chains. | J Biol Chem | 2013 | https://conductscience.org/library/papers/24142697 | PubMed |
| 17 | 21,507,961 | Covalent structural changes in unfolded GroES that lead to amyloid fibril formation detected by NMR: insight into intrinsically disordered proteins. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21507961 | PubMed |
| 18 | 20,621,282 | Protein aggregation from inclusion bodies to amyloid and biomaterials. | Adv Protein Chem Struct Biol | 2010 | https://conductscience.org/library/papers/20621282 | PubMed |
| 19 | 32,743,712 | Formulation and Administration of Biological Medicinal Products". | Pharm Res | 2020 | https://conductscience.org/library/papers/32743712 | PubMed |
| 20 | 34,516,988 | Characterization of N-Terminal Glutamate Cyclization in Monoclonal Antibody and Bispecific Antibody Using Charge Heterogeneity Assays and Hydrophobic Interaction Chromatography. | J Pharm Sci | 2022 | https://conductscience.org/library/papers/34516988 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,943,301 | Impact of Aggregation on the Immunogenicity of Therapeutic Recombinant Biological Products. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943301 | PubMed |
| 42,942,837 | The Stability-Release Paradox in Long-Acting Peptide and Protein Delivery: A Review of Material-Cargo Compatibility and Therapeutic Integrity. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942837 | PubMed |
| 42,797,299 | Pharmaceutical Strategies for Translating Klotho-Based Therapeutics: From Biologic Developability to Advanced Delivery Systems. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797299 | PubMed |
| 42,796,205 | Engineering Nanotherapeutics Through Interfacial Mechanics: Mechanobiology and Precision Drug Delivery. | Micromachines (Basel) | 2026 | https://conductscience.org/library/papers/42796205 | PubMed |
| 42,732,526 | Development of Freeze-Dried Formulations for Biopharmaceutical Drug Products Using a Design of Experiments Approach: A Case Study on Antibody-Drug Conjugates. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42732526 | PubMed |
| 42,382,974 | Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches. | Antib Ther | 2026 | https://conductscience.org/library/papers/42382974 | PubMed |
| 42,273,046 | Purification, characterization, and anticoagulant mechanism of an anticoagulant protein from marine Bacillus velezensis B01. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42273046 | PubMed |
| 41,901,238 | Formulation Matters: The Overlooked Engine of Stability and Success in Antibody-Drug Conjugates. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901238 | PubMed |
| 41,754,810 | Stability Under Different Stress Treatments of a Virus-like Particle Vaccine Based on a Recombinant Hepatitis E Vaccine. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754810 | PubMed |
| 41,638,431 | Cosolute effects reveal the nature of weak forces governing GLP-1 oligomer stability. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41638431 | PubMed |
| 41,007,619 | Advances in Techniques for the Structure and Functional Optimization of Therapeutic Monoclonal Antibodies. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007619 | PubMed |
| 40,989,105 | Opportunities in formulation development of antibody-based therapeutics. | Antib Ther | 2025 | https://conductscience.org/library/papers/40989105 | PubMed |
| 40,969,138 | Specimen Inactivation Methods for Proteomics─Comparisons of Irradiation, Chemical, and Heat Treatments on Downstream Serum Analyses. | J Proteome Res | 2025 | https://conductscience.org/library/papers/40969138 | PubMed |
| 40,935,928 | Insights from a Survey of Drug Formulation Experts: Challenges and Preferences in High-Concentration Subcutaneous Biologic Drug Development. | AAPS J | 2025 | https://conductscience.org/library/papers/40935928 | PubMed |
| 40,931,003 | Stability Testing Reveals Photoselective Clipping of Heavy Chain C-Terminal Amino Acids That Leads to Fragmentation and Aggregation of an Antibody Fab Fragment. | Mol Pharm | 2025 | https://conductscience.org/library/papers/40931003 | PubMed |
| 40,593,991 | Preparation and property evaluation of oral colon targeted protein delivery system with sodium alginate and chitosan. | Sci Rep | 2025 | https://conductscience.org/library/papers/40593991 | PubMed |
| 40,578,813 | Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations. | Mol Pharm | 2025 | https://conductscience.org/library/papers/40578813 | PubMed |
| 39,895,742 | Comprehensive Physicochemical Characterization and in Vitro Human Cell Culture Studies of an Innovative Biocompatible and Biodegradable Silk-Derived Protein Hydrolysate, SDP-4. | ACS Omega | 2025 | https://conductscience.org/library/papers/39895742 | PubMed |
| 39,635,133 | Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development. | iScience | 2024 | https://conductscience.org/library/papers/39635133 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38937372
GET https://conductscience.org/api/papers/v1/38937372/references?page=2